HARRY F. DOWLING, M.D.; THEODORE J. ABERNETHY, M.D.
This content is PDF only. Please click on the PDF icon to access.
The beneficial effect of sulfapyridine on the course and outcome of most cases of pneumococcus pneumonia has now been definitely established. A more or less rapid drop in temperature, followed by gradual disappearance of toxicity, may be expected. The temperature usually remains at normal or nearly normal levels, and the patient recovers completely. In a small but definite group of cases, however, the temperature rises again, with the accompaniment of some degree of toxicity. In our experience such a phenomenon is more frequent in sulfapyridine-treated patients than in patients recovering spontaneously or after treatment with specific serum. When such a
DOWLING HF, ABERNETHY TJ. THE CAUSES OF SECONDARY FEVER IN SULFAPYRIDINE-TREATED PNEUMONIA1. Ann Intern Med. ;14:1815–1826. doi: 10.7326/0003-4819-14-10-1815
Download citation file:
Published: Ann Intern Med. 1941;14(10):1815-1826.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use